Post Marketing Surveillance to Observe Safety and Effectiveness of CABOMETYX™ in Korea.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Know the risks and potential benefits of clinical studies and talk to your health care provider before participating.
Read our disclaimer for details.
The objective of this Post Marketing Surveillance (PMS) is to collect and describe safety and effectiveness profile of Cabometyx™ in real clinical practice setting, according to the approved labelling after the approval of marketing authorization.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Patients administrated Cabometyx™ at the site (Institutions)
Patients who meet 'Indications' of Cabometyx™ label
Patients who are treated with Cabometyx™ for the first time according to Cabometyx™ label
Patients who are aged 18 years or older
Patients who are willing to provide written consent after being informed of this surveillance
Patients who are contraindicated for Cabometyx™ based on Cabometyx™ label